Immunotherapy in renal diseases

Med Clin North Am. 2012 May;96(3):545-64, x. doi: 10.1016/j.mcna.2012.04.007. Epub 2012 May 22.

Abstract

Immunotherapy has been used for the treatment of renal diseases for a long time, and there has been significant progress in such treatment. This review focuses on the use of immunotherapy for the treatment of glomerular diseases. The use of immunosuppression in the treatment of minimal change disease, membranous nephropathy, primary focal segmental glomerulosclerosis, lupus nephritis, immunoglobulin-A nephropathy, antineutrophil cytoplasmic antibody-associated disease, and anti-glomerular basement membrane disease is discussed.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Azathioprine / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Cyclosporine / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Diseases / immunology
  • Kidney Diseases / therapy*
  • Methotrexate / therapeutic use
  • Plasmapheresis
  • Prognosis
  • Recurrence
  • Rituximab

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal, Murine-Derived
  • Immunosuppressive Agents
  • Rituximab
  • Cyclosporine
  • Cyclophosphamide
  • Azathioprine
  • Methotrexate